Literature DB >> 21728172

Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.

Susanna Commandeur1, May Y Lin, Krista E van Meijgaarden, Annemieke H Friggen, Kees L M C Franken, Jan W Drijfhout, Gro E Korsvold, Fredrik Oftung, Annemieke Geluk, Tom H M Ottenhoff.   

Abstract

More than 2 billion individuals are latently infected with Mycobacterium tuberculosis (Mtb). Knowledge of the key Mtb antigens and responding T-cell subsets mediating protection against Mtb is critical for developing improved tuberculosis (TB) vaccines. We previously reported that Mtb DosR-regulon-encoded antigens are recognized well by human T cells in association with control of Mtb infection. The characteristics of the responding T-cell subsets, however, remained unidentified. We have therefore studied the cytokine production and memory phenotypes of Mtb DosR-regulon-encoded antigen-specific T cells from individuals who had been infected with Mtb decades ago, yet never developed TB (long-term latent Mtb-infected individuals). Using multi-parameter flow cytometry and intracellular cytokine staining for IFN-γ, TNF-α and IL-2, we found double and single cytokine-producing CD4(+) as well as CD8(+) T cells to be the most prominent subsets, particularly IFN-γ(+) TNF-α(+) CD8(+) T cells. The majority of these T cells comprised effector memory and effector T cells. Furthermore, CFSE labeling revealed strong CD4(+) and CD8(+) T-cell proliferative responses induced by several "immunodominant" Mtb DosR antigens and their specific peptide epitopes. These findings demonstrate the prominent presence of double- and monofunctional CD4(+) and CD8(+) T-cell responses in naturally protected individuals and support the possibility of designing Mtb DosR antigen-based TB vaccines.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21728172     DOI: 10.1002/eji.201141602

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  37 in total

Review 1.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

2.  Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia.

Authors:  Leonar Arroyo; Mauricio Rojas; Kees L M C Franken; Tom H M Ottenhoff; Luis F Barrera
Journal:  Clin Vaccine Immunol       Date:  2016-10-04

Review 3.  Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation.

Authors:  Ashley V Veatch; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2017-09-11       Impact factor: 17.079

4.  Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells.

Authors:  Teresa Prezzemolo; Krista E van Meijgaarden; Kees L M C Franken; Nadia Caccamo; Francesco Dieli; Tom H M Ottenhoff; Simone A Joosten
Journal:  Eur J Immunol       Date:  2017-12-15       Impact factor: 5.532

Review 5.  Protection versus pathology in tuberculosis: recent insights.

Authors:  Andrea M Cooper; Egidio Torrado
Journal:  Curr Opin Immunol       Date:  2012-05-19       Impact factor: 7.486

6.  Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis.

Authors:  Desta Kassa; Leonie Ran; Wudneh Geberemeskel; Mekashaw Tebeje; Amelewerk Alemu; Alemayehu Selase; Belete Tegbaru; Kees L M C Franken; Annemieke H Friggen; Krista E van Meijgaarden; Tom H M Ottenhoff; Dawit Wolday; Tsehaynesh Messele; Debbie van Baarle
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

7.  Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.

Authors:  Mariateresa Coppola; Susan J F van den Eeden; Louis Wilson; Kees L M C Franken; Tom H M Ottenhoff; Annemieke Geluk
Journal:  Clin Vaccine Immunol       Date:  2015-07-22

8.  Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.

Authors:  I Sauzullo; R Scrivo; F Mengoni; A Ermocida; M Coppola; G Valesini; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

9.  The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.

Authors:  Bianca R Mothé; Cecilia S Lindestam Arlehamn; Courtney Dow; Myles B C Dillon; Roger W Wiseman; Patrick Bohn; Julie Karl; Nadia A Golden; Trey Gilpin; Taylor W Foreman; Mark A Rodgers; Smriti Mehra; Thomas J Scriba; JoAnne L Flynn; Deepak Kaushal; David H O'Connor; Alessandro Sette
Journal:  Tuberculosis (Edinb)       Date:  2015-08-28       Impact factor: 3.131

Review 10.  Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis.

Authors:  Sara C Auld; N Sarita Shah; Ted Cohen; Neil A Martinson; Neel R Gandhi
Journal:  Respirology       Date:  2018-06-05       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.